Na Fu

1.4k total citations
50 papers, 1.0k citations indexed

About

Na Fu is a scholar working on Epidemiology, Molecular Biology and Hepatology. According to data from OpenAlex, Na Fu has authored 50 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 14 papers in Molecular Biology and 11 papers in Hepatology. Recurrent topics in Na Fu's work include Liver Disease Diagnosis and Treatment (16 papers), Liver physiology and pathology (5 papers) and Hepatitis C virus research (5 papers). Na Fu is often cited by papers focused on Liver Disease Diagnosis and Treatment (16 papers), Liver physiology and pathology (5 papers) and Hepatitis C virus research (5 papers). Na Fu collaborates with scholars based in China, United States and Australia. Na Fu's co-authors include Yuemin Nan, Suxian Zhao, Rongqi Wang, Yunfeng Lin, Yuguo Zhang, Jun Yu, Jinghua Du, Jingmin Zhao, Wenjuan Wu and Jiong Qin and has published in prestigious journals such as Journal of the American Chemical Society, Nano Letters and Langmuir.

In The Last Decade

Na Fu

48 papers receiving 986 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Na Fu China 19 404 320 185 163 135 50 1.0k
Zhenghong Li China 23 700 1.7× 251 0.8× 196 1.1× 136 0.8× 85 0.6× 68 1.5k
F.A. Giannone Italy 18 386 1.0× 359 1.1× 205 1.1× 334 2.0× 88 0.7× 35 1.1k
Xiaolei Liu China 20 581 1.4× 196 0.6× 152 0.8× 101 0.6× 180 1.3× 95 1.2k
Xuejiao Chen China 16 462 1.1× 228 0.7× 289 1.6× 61 0.4× 98 0.7× 68 1.2k
Shanshan Cui China 19 506 1.3× 102 0.3× 205 1.1× 94 0.6× 127 0.9× 49 1.1k
Qin Zhu China 22 622 1.5× 276 0.9× 340 1.8× 42 0.3× 77 0.6× 74 1.4k
Xiang Chen China 21 757 1.9× 151 0.5× 209 1.1× 53 0.3× 132 1.0× 74 1.5k
Xiaoyu Cheng China 19 421 1.0× 147 0.5× 150 0.8× 42 0.3× 128 0.9× 75 1.0k
Xiaoyun Li China 16 359 0.9× 193 0.6× 167 0.9× 92 0.6× 42 0.3× 53 1.1k
Fuquan Wu China 16 638 1.6× 486 1.5× 330 1.8× 330 2.0× 103 0.8× 22 1.7k

Countries citing papers authored by Na Fu

Since Specialization
Citations

This map shows the geographic impact of Na Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Fu more than expected).

Fields of papers citing papers by Na Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Na Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Fu. The network helps show where Na Fu may publish in the future.

Co-authorship network of co-authors of Na Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Na Fu. A scholar is included among the top collaborators of Na Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Na Fu. Na Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dong, Shiming, et al.. (2023). Heme oxygenase‐1 prevents non‐alcoholic steatohepatitis through modulating mitochondrial quality control. Acta Physiologica. 237(3). e13918–e13918. 9 indexed citations
2.
Jiang, Zhengyu, Ermanno Malagola, Na Fu, et al.. (2023). Microbial-Dependent Recruitment of Immature Myeloid Cells Promotes Intestinal Regeneration. Cellular and Molecular Gastroenterology and Hepatology. 17(3). 321–346. 2 indexed citations
3.
4.
Li, Yue, Wentao Liu, Xiaolong Yue, et al.. (2021). Effective Disease Control After Combinatorial Treatment with a PD-1 Antibody and an mTOR Inhibitor for Recurrent Ovarian Clear Cell Carcinomas: A Case Report and Literature Review. OncoTargets and Therapy. Volume 14. 5429–5434. 4 indexed citations
5.
Li, Qinrui, Na Fu, Ying Han, & Jiong Qin. (2021). Pediatric Autoimmune Encephalitis and Its Relationship With Infection. Pediatric Neurology. 120. 27–32. 8 indexed citations
6.
Li, Qinrui, Jingjing Liang, Na Fu, Ying Han, & Jiong Qin. (2021). A Ketogenic Diet and the Treatment of Autism Spectrum Disorder. Frontiers in Pediatrics. 9. 650624–650624. 52 indexed citations
7.
Du, Jinghua, Weiguang Ren, Qingshan Zhang, et al.. (2020). Heme Oxygenase‐1 Suppresses Wnt Signaling Pathway in Nonalcoholic Steatohepatitis‐Related Liver Fibrosis. BioMed Research International. 2020(1). 4910601–4910601. 9 indexed citations
8.
Li, Dongdong, Jinghua Du, Shiming Dong, et al.. (2020). Heme oxygenase-1 alleviated non-alcoholic fatty liver disease via suppressing ROS-dependent endoplasmic reticulum stress. Life Sciences. 253. 117678–117678. 34 indexed citations
9.
Fu, Na, Dongdong Li, Yu Lu, et al.. (2020). Clusterin contributes to hepatitis C virus-related hepatocellular carcinoma by regulating autophagy. Life Sciences. 256. 117911–117911. 17 indexed citations
10.
Fu, Na, Zhengyu Jiang, Woosook Kim, et al.. (2020). Acute Intestinal Inflammation Depletes/Recruits Histamine-Expressing Myeloid Cells From the Bone Marrow Leading to Exhaustion of MB-HSCs. Cellular and Molecular Gastroenterology and Hepatology. 11(4). 1119–1138. 6 indexed citations
11.
Fu, Na, Wenjie Chen, Jingjing Liang, et al.. (2018). Prognostic Value of Electroencephalography in Hypothermia-Treated Neonates With Hypoxic-Ischemic Encephalopathy: A Meta-Analysis. Pediatric Neurology. 93. 3–10. 11 indexed citations
12.
Wang, Yang, Jinghua Du, Na Fu, et al.. (2017). MiR-130a-3p attenuates activation and induces apoptosis of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis by directly targeting TGFBR1 and TGFBR2. Cell Death and Disease. 8(5). e2792–e2792. 65 indexed citations
13.
Zhao, Suxian, Na Fu, Shanshan Su, et al.. (2016). Involvement of the Interleukin-23/Interleukin-17 Axis in Chronic Hepatitis C Virus Infection and Its Treatment Responses. International Journal of Molecular Sciences. 17(7). 1070–1070. 19 indexed citations
14.
Shi, Sirong, Jing Xie, Juan Zhong, et al.. (2016). Effects of low oxygen tension on gene profile of soluble growth factors in co‐cultured adipose‐derived stromal cells and chondrocytes. Cell Proliferation. 49(3). 341–351. 43 indexed citations
15.
Shao, Xiaoru, Meiqi Wang, Shuwen Deng, et al.. (2016). Peroxisome Proliferator-Activated Receptor-γ: Master Regulator of Adipogenesis and Obesity. Current Stem Cell Research & Therapy. 11(3). 282–289. 98 indexed citations
16.
Xiong, Hui, Katsumi Higaki, Cuijie Wei, et al.. (2012). Genotype/phenotype of 6 Chinese cases with Niemann–Pick disease type C. Gene. 498(2). 332–335. 9 indexed citations
17.
Liu, Yanyan, Xinhua Bao, Dong Wang, et al.. (2012). Allelic Variations of Glut-1 Deficiency Syndrome: The Chinese Experience. Pediatric Neurology. 47(1). 30–34. 11 indexed citations
18.
Nan, Yuemin, Suxian Zhao, Fang Han, et al.. (2010). Heme oxygenase-1 prevents non-alcoholic steatohepatitis through suppressing hepatocyte apoptosis in mice. Lipids in Health and Disease. 9(1). 124–124. 35 indexed citations
19.
Nan, Yuemin, Wenjuan Wu, Na Fu, et al.. (2009). Antioxidants vitamin E and 1-aminobenzotriazole prevent experimental non-alcoholic steatohepatitis in mice. Scandinavian Journal of Gastroenterology. 44(9). 1121–1131. 90 indexed citations
20.
Nan, Yuemin, Na Fu, Wenjuan Wu, et al.. (2008). Rosiglitazone prevents nutritional fibrosis and steatohepatitis in mice. Scandinavian Journal of Gastroenterology. 44(3). 358–365. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhenghong Li Breakdown of academic impact, for papers by F.A. Giannone Breakdown of academic impact, for papers by Xiaolei Liu Breakdown of academic impact, for papers by Xuejiao Chen Breakdown of academic impact, for papers by Shanshan Cui Breakdown of academic impact, for papers by Qin Zhu Breakdown of academic impact, for papers by Xiang Chen Breakdown of academic impact, for papers by Xiaoyu Cheng Breakdown of academic impact, for papers by Xiaoyun Li Breakdown of academic impact, for papers by Fuquan Wu
Rankless by CCL
2026